Cardiovascular health in migrants: current status and issues for prevention. A collaborative multidisciplinary task

Pietro A Modesti1, Stefano Bianchi, Claudio Borghi

  • 1aDepartment of Medicina Sperimentale e Clinica, University of Florence, Florence bDepartment of Medicina Interna, Nefrologia e Dialisi, Ospedali Riuniti di Livorno, Livorno cDepartment of Scienze Mediche e Chirurgiche, S.Orsola-Malpighi University Hospital, Bologna dDepartment of Malattie Cardiovascolari, University of Siena, Siena eDepartment of Nephrology, Second University of Naples, Naples, Italy fInstitute d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain gDepartment of Emergenza e dei trapianti d'Organo DETO, Sezione di Malattie dell'Apparato Cardiovascolare, University of Bari, Bari hDepartment of Scienze Cardiovascolari, Respiratorie, Geriatriche e Nefrologiche, University 'La Sapienza', Rome iAS Department of Cardiology, Brindisi District jDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia kDivision of Cardiology, Dipartimanto di Medicina Interna, Malattie Cardiovascolari e Nefrourologiche, University of Palermo, Palermo lDepartment of Medicina Sperimentale e Clinica, University of Florence, Florence mDivision of Cardiology, ASL BR, Brindisi nUOD Telemedicina, Dipartimento Cardiovascolare, A.O.San Camillo-Forlanini, Roma oDivision of Cardiology, Department of Fisiopatologia Clinica - Sezione di Endocrinologia, University of Florence, Florence pDivision of Cardiology, AOU Sassari, Sassari qDepartment of Emergenza e dei trapianti d'Organo DETO, Sezione di Malattie dell'Apparato Cardiovascolare, University of Bari, Bari rDepartment of Advanced Biomedical Sciences, Federico II University, Naples sDivision of Cardiology, Department of Medicina Clinica e Molecolare, Facoltà di Medicina e Psicologia Università di Roma 'Sapienza' - Azienda Ospedaliera Sant'Andrea, and IRCCS Neuromed, Rome tDepartment Cardio Toracico e Vascolare, University of Pisa, Pisa uDepartment of Scienze Mediche e Chirurgiche, University of Foggia, Foggia, Italy.

Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
888
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
999
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
534
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
442
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
746
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K